1. STRUCTURE | |
---|---|
2. PRODUCT NAME & DETAILS | |
---|---|
Product Name | 6-Nitro-7-chloro-4-hydroxy quinazoline |
Product Code | P6055 |
CAS No | 53449-14-2 |
HS Code | 2933.99.00 |
Molecular Wt. | 225.590 |
Molecular Formula | C8H4CIN3O3 |
3. SPECIFICATION
|
|
Physical Appearance
|
Pale Yellow Powder to Light Brown Powder
|
Melting Point
|
> 280 °C
|
Identification (HPLC)
|
RT of Sample Should Matches with Standard
|
Moisture Content (KF)
|
NMT 0.5%
|
7 Chloro-4[1h]-quinazolinone
|
MAX 0.5%
|
Any Others Impurity 5,7-Dlchloro-4[1h]qulnazollnone
|
MAX 0.1%
|
+7-chloro-Bnitro-4[1 h]quinazolin One
|
MAX 1.5%
|
Assay (HPLC)
|
NLT 98%
|
4. APPLICATION | It is use as intermediate of Afatinib and Afatinib Dimaleate.
It is use in Anti.Cancer, Oncology Drug. |
5. HAZARD CLASSIFICATION | 6-Nltro-7-chloro-4-hydroxy qulnazoline is Hazardous Substance.
|
6. CAPACITY | 2 MT Per Month.
|
7. STORAGE CONDITION
|
Store In closed container at ambient temperature.Avoid direct sunllght.
|
Disclaimer |
---|
Typical properties should not be considered as specification. Product covered by valid patents are not offered or supplied for commercial use. The Patent position should be verified by the customer. Products will not be supplied to countries where they could be in conflict with existing patents. Products currently covered by valid US patents are offered for R&D; use in accordance with 35 USC 271 (e) (I) Above information is given in good faith and without warrenty. |
The above information is given in good faith and is without warranty